The hydrolysis of cell surface glycosphingolipids by endoglycoceramidase reduces epidermal growth factor receptor phosphorylation in A431 cells

Li Ji, Makoto Ito, Gu Zhang, Tatsuya Yamagata

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

This paper presents a new method to evaluate the biological significance of glycosphingolipids (GSLs) using a GSL-spedfic enzyme, endoglycoceramidase (EGCase), by which GSL-sugar chains are removed from the cell surface of living cells. In this report, the effects of EGCase on epidermal growth factor (EGF)-dependent tyrosine-specific EGF receptor (EGFR) phosphorylation of A431 cells are described. After treatment of A431 cells with EGCase II (20 mU/ml) in the presence of the activator for 12 h, all acidic GSLs tested were reduced to ∼70% of control, but no hydrolysis occurred on Galα1,4Galcβ1,4Glcβ1,1Cer (Gb3Cer) and GalNAcpβ1 Galα1,4Galβ1,4Glcβ1,1Cer (Gb4Cer). In plasma membrane fractions of A431 cells, the reduction of gangliosides by EGCase II was found to be much faster than that of intact cells and reached 54.8% reduction of total gangliosides after 2 h incubation with the enzyme. EGF-dependent phosphorylation of EGFR of A431 cells was inhibited by the reduction of cell surface GSLs by EGCase when either intact A431 cells or their plasma membrane fractions were used, while EGF binding to their receptors was not changed. Neither hydrolysis of cell surface GSLs nor reduction of EGFR phosphorylation occurred when A431 cells were incubated with the activator or EGCase alone. The exogenous addition of ceramides or sphingosines, and treatment of cell membranes with sphingomyelinase, had no effect on the EGFR phosphorylation of purified membrane fractions, while the inhibitory effect of EGCase II on EGFR phosphorylation was restored by the addition of GM3-sugar chains, but not by lactose or sialic acid. The data presented in this paper indicate that the removal of sugar chains of GSLs, but not the accumulation of ceramides, reduces EGFdependent EGFR phosphorylation of A431 cells, suggesting that endogenous GSLs, possibly GM3, may be one of the integral constituents for supporting (or stimulating) the EGFR phosphorylation of A431 cells in situ.

Original languageEnglish
Pages (from-to)343-350
Number of pages8
JournalGlycobiology
Volume5
Issue number3
DOIs
Publication statusPublished - May 1995

Fingerprint

endoglycoceramidase
Glycosphingolipids
Phosphorylation
Epidermal Growth Factor Receptor
Hydrolysis
Cell membranes
Epidermal Growth Factor
Sugars
Gangliosides
Ceramides
Acidic Glycosphingolipids
Sphingomyelin Phosphodiesterase
Sphingosine
Cell Membrane
N-Acetylneuraminic Acid
Enzymes
Lactose
Tyrosine

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

The hydrolysis of cell surface glycosphingolipids by endoglycoceramidase reduces epidermal growth factor receptor phosphorylation in A431 cells. / Ji, Li; Ito, Makoto; Zhang, Gu; Yamagata, Tatsuya.

In: Glycobiology, Vol. 5, No. 3, 05.1995, p. 343-350.

Research output: Contribution to journalArticle

@article{d98fb3585a1845aaa9ca1b55b90654b4,
title = "The hydrolysis of cell surface glycosphingolipids by endoglycoceramidase reduces epidermal growth factor receptor phosphorylation in A431 cells",
abstract = "This paper presents a new method to evaluate the biological significance of glycosphingolipids (GSLs) using a GSL-spedfic enzyme, endoglycoceramidase (EGCase), by which GSL-sugar chains are removed from the cell surface of living cells. In this report, the effects of EGCase on epidermal growth factor (EGF)-dependent tyrosine-specific EGF receptor (EGFR) phosphorylation of A431 cells are described. After treatment of A431 cells with EGCase II (20 mU/ml) in the presence of the activator for 12 h, all acidic GSLs tested were reduced to ∼70{\%} of control, but no hydrolysis occurred on Galα1,4Galcβ1,4Glcβ1,1Cer (Gb3Cer) and GalNAcpβ1 Galα1,4Galβ1,4Glcβ1,1Cer (Gb4Cer). In plasma membrane fractions of A431 cells, the reduction of gangliosides by EGCase II was found to be much faster than that of intact cells and reached 54.8{\%} reduction of total gangliosides after 2 h incubation with the enzyme. EGF-dependent phosphorylation of EGFR of A431 cells was inhibited by the reduction of cell surface GSLs by EGCase when either intact A431 cells or their plasma membrane fractions were used, while EGF binding to their receptors was not changed. Neither hydrolysis of cell surface GSLs nor reduction of EGFR phosphorylation occurred when A431 cells were incubated with the activator or EGCase alone. The exogenous addition of ceramides or sphingosines, and treatment of cell membranes with sphingomyelinase, had no effect on the EGFR phosphorylation of purified membrane fractions, while the inhibitory effect of EGCase II on EGFR phosphorylation was restored by the addition of GM3-sugar chains, but not by lactose or sialic acid. The data presented in this paper indicate that the removal of sugar chains of GSLs, but not the accumulation of ceramides, reduces EGFdependent EGFR phosphorylation of A431 cells, suggesting that endogenous GSLs, possibly GM3, may be one of the integral constituents for supporting (or stimulating) the EGFR phosphorylation of A431 cells in situ.",
author = "Li Ji and Makoto Ito and Gu Zhang and Tatsuya Yamagata",
year = "1995",
month = "5",
doi = "10.1093/glycob/5.3.343",
language = "English",
volume = "5",
pages = "343--350",
journal = "Glycobiology",
issn = "0959-6658",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - The hydrolysis of cell surface glycosphingolipids by endoglycoceramidase reduces epidermal growth factor receptor phosphorylation in A431 cells

AU - Ji, Li

AU - Ito, Makoto

AU - Zhang, Gu

AU - Yamagata, Tatsuya

PY - 1995/5

Y1 - 1995/5

N2 - This paper presents a new method to evaluate the biological significance of glycosphingolipids (GSLs) using a GSL-spedfic enzyme, endoglycoceramidase (EGCase), by which GSL-sugar chains are removed from the cell surface of living cells. In this report, the effects of EGCase on epidermal growth factor (EGF)-dependent tyrosine-specific EGF receptor (EGFR) phosphorylation of A431 cells are described. After treatment of A431 cells with EGCase II (20 mU/ml) in the presence of the activator for 12 h, all acidic GSLs tested were reduced to ∼70% of control, but no hydrolysis occurred on Galα1,4Galcβ1,4Glcβ1,1Cer (Gb3Cer) and GalNAcpβ1 Galα1,4Galβ1,4Glcβ1,1Cer (Gb4Cer). In plasma membrane fractions of A431 cells, the reduction of gangliosides by EGCase II was found to be much faster than that of intact cells and reached 54.8% reduction of total gangliosides after 2 h incubation with the enzyme. EGF-dependent phosphorylation of EGFR of A431 cells was inhibited by the reduction of cell surface GSLs by EGCase when either intact A431 cells or their plasma membrane fractions were used, while EGF binding to their receptors was not changed. Neither hydrolysis of cell surface GSLs nor reduction of EGFR phosphorylation occurred when A431 cells were incubated with the activator or EGCase alone. The exogenous addition of ceramides or sphingosines, and treatment of cell membranes with sphingomyelinase, had no effect on the EGFR phosphorylation of purified membrane fractions, while the inhibitory effect of EGCase II on EGFR phosphorylation was restored by the addition of GM3-sugar chains, but not by lactose or sialic acid. The data presented in this paper indicate that the removal of sugar chains of GSLs, but not the accumulation of ceramides, reduces EGFdependent EGFR phosphorylation of A431 cells, suggesting that endogenous GSLs, possibly GM3, may be one of the integral constituents for supporting (or stimulating) the EGFR phosphorylation of A431 cells in situ.

AB - This paper presents a new method to evaluate the biological significance of glycosphingolipids (GSLs) using a GSL-spedfic enzyme, endoglycoceramidase (EGCase), by which GSL-sugar chains are removed from the cell surface of living cells. In this report, the effects of EGCase on epidermal growth factor (EGF)-dependent tyrosine-specific EGF receptor (EGFR) phosphorylation of A431 cells are described. After treatment of A431 cells with EGCase II (20 mU/ml) in the presence of the activator for 12 h, all acidic GSLs tested were reduced to ∼70% of control, but no hydrolysis occurred on Galα1,4Galcβ1,4Glcβ1,1Cer (Gb3Cer) and GalNAcpβ1 Galα1,4Galβ1,4Glcβ1,1Cer (Gb4Cer). In plasma membrane fractions of A431 cells, the reduction of gangliosides by EGCase II was found to be much faster than that of intact cells and reached 54.8% reduction of total gangliosides after 2 h incubation with the enzyme. EGF-dependent phosphorylation of EGFR of A431 cells was inhibited by the reduction of cell surface GSLs by EGCase when either intact A431 cells or their plasma membrane fractions were used, while EGF binding to their receptors was not changed. Neither hydrolysis of cell surface GSLs nor reduction of EGFR phosphorylation occurred when A431 cells were incubated with the activator or EGCase alone. The exogenous addition of ceramides or sphingosines, and treatment of cell membranes with sphingomyelinase, had no effect on the EGFR phosphorylation of purified membrane fractions, while the inhibitory effect of EGCase II on EGFR phosphorylation was restored by the addition of GM3-sugar chains, but not by lactose or sialic acid. The data presented in this paper indicate that the removal of sugar chains of GSLs, but not the accumulation of ceramides, reduces EGFdependent EGFR phosphorylation of A431 cells, suggesting that endogenous GSLs, possibly GM3, may be one of the integral constituents for supporting (or stimulating) the EGFR phosphorylation of A431 cells in situ.

UR - http://www.scopus.com/inward/record.url?scp=0029054205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029054205&partnerID=8YFLogxK

U2 - 10.1093/glycob/5.3.343

DO - 10.1093/glycob/5.3.343

M3 - Article

C2 - 7655171

AN - SCOPUS:0029054205

VL - 5

SP - 343

EP - 350

JO - Glycobiology

JF - Glycobiology

SN - 0959-6658

IS - 3

ER -